This is a news story, published by Doctors Without Borders - USA, that relates primarily to Epicentre news.
For more Epicentre news, you can click here:
more Epicentre newsFor more vaccine development news, you can click here:
more vaccine development newsFor more news from Doctors Without Borders - USA, you can click here:
more news from Doctors Without Borders - USAOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
only Ebola vaccine. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Ebola epidemic news, largest Ebola epidemic news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Ebola virusDoctors Without Borders - USA
•
79% Informative
The Lancet Infectious Diseases published a study this week by Doctors Without Borders/Médecins Sans Frontières' ( MSF ) research arm Epicentre .
The study looked at the rVSVG-ZEBOV-GP vaccine in particular, which is the only Ebola vaccine recommended for use by the World Health Organization for people at high risk of contracting the disease during an epidemic.
VR Score
90
Informative language
96
Neutral language
56
Article tone
formal
Language
English
Language complexity
71
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links